ĒnelAtlasSearch the Atlas

Peptides

Mitochondrial

Cellular energy and the powerhouse

10 peptides. None rests on strong human evidence. Ordered with the best evidenced first.

10 peptides in Mitochondrial

APJ Receptor Agonist Tridecapeptide

An endogenous APJ-receptor peptide that is inotropic, vasodilatory, anti-fibrotic, and promotes mitochondrial biogenesis. Plasma levels fall with heart failure and aging.

Cardiac / MetabolicNo approved product; investigational only. Native Apelin-13 has been used solely in short-term human research infusions, and analog programs (Novartis CLR325, BMS-986224, AMG 986) did not advance to approval.

Elamipretide · Szeto-Schiller Peptide 31

Engineered to penetrate the inner mitochondrial membrane. FDA-approved September 2025.

Mitochondrial / CardioprotectiveFDA accelerated approval Sept 2025 (Forzinity, elamipretide HCl) for muscle strength in Barth syndrome only, in patients >=30 kg; granted on an intermediate/surrogate endpoint with confirmatory clinical-benefit trials still required. Preceded by an Aug 2021 refuse-to-file and a May 2025 complete response letter. No approval for any other indication; heart-failure and mitochondrial-myopathy programs failed.

Ala-Glu-Asp-Arg (AEDR) Cardiac Peptide Bioregulator

A Khavinson short-peptide (cytogen) heart bioregulator with the sequence Ala-Glu-Asp-Arg (AEDR). Russian preclinical, in-vitro and animal data describe effects on cardiac gene expression, cytoskeletal protein synthesis and cardiomyocyte apoptosis, with no independent replication and no published human RCTs.

Cardiac BioregulatorNot Approved (USA); sold research-use-only, unapproved as a drug

Stabilized MOTS-c Analog

A stabilized synthetic analog of MOTS-c in clinical development to overcome the native peptide's synthesis and stability challenges. Earliest stage of development.

Mitochondrial AnalogNo FDA approval. The one clinically tested analog, CB4211, completed a single Phase 1a/1b study and was discontinued when CohBar dissolved; consumer 'MOTS-c analog' products are sold as research chemicals, not for human use.

Small Humanin-Like Peptide 2

A member of the humanin family from the USC mitochondrial-peptide program. Higher plasma levels associate with longer survival; anti-apoptotic and neuroprotective in preclinical models.

Mitochondrial-Derived PeptideNot FDA approved for any indication; no approved drug application, no completed human clinical trials. Available only as a research reagent, not for human use.

Lys-Glu-Asp Vascular Bioregulator

A Khavinson tripeptide bioregulator targeting vascular tissue and endothelial function in aging. Russian data only.

Vascular BioregulatorNot FDA approved for any indication; not evaluated by the FDA. Sold in the United States only as a research chemical labeled not for human consumption; in Russia it is marketed as a non-prescription peptide bioregulator/dietary preparation.